| Lightcalls.com |
|
|
![]() |
An ancient herb for fresh medicine...An ancient herb for fresh medicine. Andrographis paniculata (Nees) has been used for centuries in China, India, and Thailand to luckily treat upper respiratory tract infection, excitement sore throat, herpes, and an array of other infectious and chronic diseases. A. paniculata is also used extensively in Scandinavian countries to obstruct and treat common colds. Scientific research in the last sum of two units decades has also confirmed A. paniculata as an effective painkiller, as well as a descendants clot preventative and buster. This botanical also acts to lower vital current sugar, reduce fever and inflammation, stop diarrhea, lower vital fluid pressure, and reduce the incidence of sore s A. paniculata protects the liver from toxic substances and has antitumor properties, with important implications for cancer treatment. Andrographis has extremely grave toxicity, although women who wish to become pregnant should not use it since it has been shown to have a contraceptive effect in what way does this botanical work? The active constituents of this botanical are a cluster of compounds called andrographolides. A. paniculata has been the make submissive of exciting research that involves the use of a screening technique called "signal transduction technology." Using signal transduction technology, extracts of A. paniculata have been plant to counteract interference with the solitary abode; squalid cycle. Such interference is the basis for the increase of cancer or infection with viruses, like as HIV. When cancer tip overs normal development, the cells do not mature. The more immature the solitary abode; squalids the more unfavorable the outcome: the cancer will be augmented and spread more rapidly. If a cancer confined apartment can be made to mature, it will not have the ability to improve out of control. Immune body stimulator A. paniculata is also a efficacious stimulator of the immune rejoinder making it effective against a innkeeper of infectious and cancer-causing agents. Andrographolides are idea to enhance immune system functions, like as production of white vital current cells (scavengers of bacteria and other foreign matter). like capabilities make A. paniculata effective for the prevention and treatment of colds In a consideration published in the journal Phytomedicine, researchers using an A. paniculata preparation establish a preventive effect against the universal cold. Using 1,200 mg/day for three month there was a significant decrease in the incidence of boreals in school children. excitement reducer Researchers also standarded A. paniculata for its ability to make less fever. While the pain-killing activity of andrographolide was weak compared to aspirin, the fever-reducing activity was comparable. Unlike aspirin, however, andrographolide did not create stomach distress. A. paniculata and the validation of its action at signal transduction technology heralds a novel era in the use and acceptance of herbal medicine. REFERENCES Caceres, DD Hancke, JL Burgo R.A., Wikman, GK "Prevention of often met with colds with Andrographis paniculata dried extract: A pilot double blind trial," Phytomedicine 4(2):101-104 1997 Deng WL "Outline of present clinical and pharmacological research upon Andrographis paniculata in China," Newsletter of Chinese Herbal M 10:27-31 1978b Deng WL "Preliminary studies forward the pharmacology of the andrographis work dihydroandrographolide sodium succinate," Newsletters of Chinese Herbal M 8:26-28 1978a. Madav, HC Tripathi, T Mishra, SK "Analgesic, antipyretic and antiulcerogenic efficiencys of andrographolide," Indian J Pharm Sci 57(3):121-125 1995 Matsuda, T Kuroyanagi, M Sugiyama, s Umehara, K., Ueno, A., Nishi, K "Cell differentiation-inducing diterpenes from Andrographis paniculata, Nees" Chem Pharm rescript (Tokyo). 42(6):1216-1225, 1994. Siripong, P Kongkathip, B Preechanukool, K Picha, P Tunsuwan, K and Taylor, WC "Cytotoxic diterpenoid constituents from Andrographis paniculata, borns leaves," J Sci Soc Thailand 18(4):187-194 1992 Yin, J Guo L Contemporary Traditional Chinese Medicine. Bejing: Xie Yuan, 1993 Jean Barilla, M is the same of the nation's foremost medical and nutrition masters The exciting details of andrographis, its history, use, and subsequent time promise can be found in her work the Good Health Guide: Andrographis paniculata: Fighting Cancer and AIDS (Keats Publishing, May 1999) COPYRIGHT 1999 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |